Novartis AG (NVS) is a publicly traded Healthcare sector company. As of August 25, 2026, NVS trades at $157.88 with a market cap of $301.95B and a P/E ratio of 0.00. NVS moved -0.53% today. Year to date, NVS is +14.62%; over the trailing twelve months it is +24.44%. Its 52-week range spans $96.91 to $170.46. Analyst consensus is neutral with an average price target of $159.00. Rallies surfaces NVS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks the latest NVS news, catalysts, market updates, source links, and AI summaries when news is available.
| Metric | Value |
|---|---|
| Price | $157.88 |
| Market Cap | $301.95B |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 4.74% |
| 52-Week High | $170.46 |
| 52-Week Low | $96.91 |
| Volume | 756.96K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
5 analysts cover NVS: 0 strong buy, 2 buy, 2 hold, 1 sell, 0 strong sell. Consensus rating is neutral. Average price target: $159.00.